معرفی
Jack Bowden serves as Professor of Biomedical Data Science at the University of Exeter Medical School and Senior Scientific Director at Novo Nordisk, Oxford, driving innovation at the intersection of academic research and pharmaceutical applications.
His educational foundation includes:
- BSc Hons Mathematics
- MSc Medical Statistics
- PhD Biostatistics
A pioneer in genetic causal inference, Bowden developed robust Mendelian randomization frameworks for public health and drug discovery over 20 years. His current research integrates genetic and non-genetic causal methods to address multi-morbidity, pharmacogenetics, and precision medicine challenges in type II diabetes, while advancing adaptive clinical trial designs with response-adaptive randomization under the Estimand framework. This work bridges statistical theory with real-world medical applications through interdisciplinary collaboration.
His professional recognition includes:
- Clarivate Web-of-Science Highly Cited Researcher (2019-present)
Though specific student supervision details are unreported, Bowden's leadership in the NIHR Exeter Biomedical Research Centre demonstrates extensive grant-funded collaboration. His dual academic-industry position enables direct translation of methodological innovations into therapeutic development, particularly through Novo Nordisk's genetics division.
Research activities are centered at the University of Exeter Medical School's RILD Building within the NIHR Exeter Biomedical Research Centre, where interdisciplinary teams leverage his causal inference frameworks for population health studies and clinical implementation.
